Recent Finacing
Recent Raise
Nuvectis Pharma is a biopharmaceutical company developing precision oncology medicines, advancing NXP800, an oral small-molecule HSF1 pathway inhibitor in preclinical/Phase I preparation for ovarian clear cell and endometrioid cancers.